Opthea Appoints Chief Commercial Officer to Lead Commercialization of OPT-302 for Wet …

Opthea’s lead product candidate OPT-302 is in pivotal Phase 3 clinical … Authorized for release to ASX by Megan Baldwin, CEO & Managing Director. Read source